Why the study?
Hepatocellular carcinoma is prevalent worldwide, and this study aimed to explore new long non-coding RNAs associated with the disease and detect their expression levels in cell lines and tissues.
Does overexpression of lncRNA NRAD1 and LINC00152 affect prognosis in patients with hepatocellular carcinoma?
Does overexpression of lncRNA NRAD1 and LINC00152 affect prognosis in patients with hepatocellular carcinoma?
High expression of lncRNA NRAD1 and LINC00152 are independent risk factors for poor prognosis in patients with hepatocellular carcinoma.
Answers are grounded in this paper and cite their sources.
NRAD1 and LINC00152 overexpression may stratify HCC prognosis; leaves open biomarker utility pending prospective validation.
BACKGROUND: Hepatocellular carcinoma (HCC) is prevalent throughout the world. The aim of this study is to explore new long non-coding RNAs (lncRNAs) associated with hepatocellular carcinoma and detect their expression levels in hepatocellular carcinoma cell lines and tissues. These results will provide new clues on further function and biomarker studies of HCC-related lncRNAs. PATIENTS AND METHODS: All patients were diagnosed as HCC between 30th, March, 2015 and 30th, July, 2018. LncRNA human gene expression microarray was applied to the profiling of lncRNAs in four cancerous tissues and the paired paracancerous tissues. Overexpression of lncRNA NRAD1 and LINC00152 was associated with decreasing OS rates, respectively (P=0.0263 and P=0.0285). Meanwhile, overexpression of NRAD1 and LINC00152 was associated with decreasing PFS rates, respectively (P=0.0174 and P=0.0041). After adjusting for competing risk factors, we identified that microvascular invasion (P=0.014), tumor size (P=0.026), lncRNA NRAD1 (P=0.001) and LINC00152P9 (P=0.036) expression levels were independent prognostic factors associated with prognosis of patients with HCC. CONCLUSION: We found lncRNA NRAD1 and LINC00152 expressed significantly higher in HCC tissues compared with non-tumorous tissues. Overexpression of lncRNA NRAD1 and LINC00152 were independent risk factors associated with the prognosis of patients with HCC.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: